Benson Hill Sells Assets Amid Bankruptcy Proceedings

The latest announcement is out from Benson Hill ( (BHILQ) ).

Benson Hill, Inc., along with its subsidiaries, filed for Chapter 11 bankruptcy on March 20, 2025, and has been operating as debtors-in-possession under the jurisdiction of the United States Bankruptcy Court for the District of Delaware. On May 23, 2025, Benson Hill completed the sale of substantially all its assets to Confluence Genetics, LLC, following a court-approved bidding process. This asset sale, conducted under Section 363 of the Bankruptcy Code, involved the assumption of certain liabilities and the termination of a $11 million debtor-in-possession credit facility. The company does not expect any proceeds from the sale to be available for distribution to its stockholders. Additionally, the board of directors underwent significant changes, with Daniel Cosgrove becoming the sole director and continuing as Interim CEO in an independent contractor capacity.

Spark’s Take on BHILQ Stock

According to Spark, TipRanks’ AI Analyst, BHILQ is a Underperform.

Benson Hill’s stock score reflects significant financial challenges, including declining revenues and high leverage, which are the primary concerns. The technical analysis does not show signs of recovery, and the negative valuation metrics further contribute to the low score. Improvements in cash flow management are noted but are insufficient to offset the broader financial instability.

To see Spark’s full report on BHILQ stock, click here.

More about Benson Hill

Average Trading Volume: 169,669

Technical Sentiment Signal: Sell

Current Market Cap: $317.9K

For an in-depth examination of BHILQ stock, go to TipRanks’ Stock Analysis page.